American Portfolios Advisors Selecta Biosciences Inc Transaction History

American Portfolios Advisors

$2.36 Trillion
Q3 2022

A detailed history of American Portfolios Advisors transactions in Selecta Biosciences Inc stock. As of the latest transaction made, American Portfolios Advisors holds 7,250 shares of SELB stock, worth $6,090. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,250

Holding current value

$6,090

% of portfolio

0.0%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Mar 17, 2023	BUY	$1.33 - $2.6 $9,642 - $18,850	7,250 New	7,250 $11.9 Million
Q3 2021 Mar 22, 2023	SELL	$3.36 - $4.62 $3,360 - $4,620	-1,000 Reduced 13.79%	6,250 $26 Million
Q2 2021 Mar 22, 2023	SELL	$2.82 - $5.01 $6,345 - $11,272	-2,250 Reduced 31.03%	5,000 $20.9 Million
Q1 2021 Mar 22, 2023	SELL	$2.92 - $5.07 $6,570 - $11,407	-2,250 Reduced 31.03%	5,000 $22.6 Million

Others Institutions Holding SELB

# of Institutions

Shares Held

4.67M

Call Options Held

Put Options Held

View Full List

About SELECTA BIOSCIENCES INC

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

More about SELB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Account

American Portfolios Advisors Selecta Biosciences Inc Transaction History